| TIAL1 Gene | |
|---|---|
| Gene Symbol | TIAL1 |
| Full Name | TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1 |
| Protein Name | TIAL1 (TIA-1-like protein) |
| Chromosomal Location | 10q11.23 |
| NCBI Gene ID | [7073](https://www.ncbi.nlm.nih.gov/gene/7073) |
| OMIM | [604713](https://www.omim.org/entry/604713) |
| Ensembl ID | ENSG00000173113 |
| UniProt ID | [Q9YKf3](https://www.uniprot.org/uniprot/Q9YKf3) |
| Protein Size | 405 amino acids |
| Molecular Weight | ~46 kDa |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Alzheimer's Disease |
TIAL1 (TIA1 Cytotoxic Granule Associated RNA Binding Protein Like 1) encodes a member of the TIA1 family of RNA-binding proteins. TIAL1 is closely related to TIA1 (encoded by a separate gene) and shares structural and functional homology, including the ability to nucleate stress granule assembly and regulate mRNA translation. Located on chromosome 10q11.23, TIAL1 is expressed predominantly in brain tissue, particularly in neurons, where it plays critical roles in the cellular stress response. [1]
The TIAL1 protein contains three RNA recognition motifs (RRMs) that enable sequence-specific binding to adenine-uridine-rich elements (AU-rich elements, AREs) in the 3' untranslated regions of messenger RNAs. This RNA-binding activity allows TIAL1 to regulate mRNA stability, localization, and translation, particularly under stress conditions. Like its paralog TIA1, TIAL1 contains a prion-like domain that enables liquid-liquid phase separation, making it a key component of stress granules—membraneless organelles that form in response to various cellular stresses. [2]
Dysregulation of TIAL1 and stress granule dynamics has emerged as an important pathogenic mechanism in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where mutations in TIA1 and related RNA-binding proteins cause aberrant stress granule assembly and persistence. Understanding the precise roles of TIAL1 in neurodegeneration provides critical insights into disease mechanisms and potential therapeutic targets. [3]
The TIAL1 gene is located on chromosome 10q11.23 and spans approximately 12 kb of genomic DNA. The gene consists of 13 exons that encode a 405-amino acid protein with a molecular weight of approximately 46 kDa. The promoter region contains regulatory elements responsive to cellular stress, including heat shock elements and antioxidant response elements, allowing for stress-inducible expression. [4]
| Property | Value |
|---|---|
| Chromosome | 10q11.23 |
| Genomic Size | ~12 kb |
| Exon Count | 13 |
| Protein Length | 405 amino acids |
| Molecular Weight | ~46 kDa |
| Transcript Variants | 2 validated isoforms |
TIAL1 is evolutionarily conserved across vertebrates, with orthologs identified in mice, zebrafish, and Drosophila. The protein shares significant sequence homology with TIA1 (approximately 70% identity), particularly in the RNA recognition motifs, suggesting functional redundancy while maintaining distinct roles in stress responses. [5]
The conservation of both TIA1 and TIAL1 across species indicates that these proteins serve essential cellular functions. Studies in model organisms have demonstrated that TIAL1 can partially compensate for TIA1 loss, but each protein has unique tissue-specific expression patterns and stress-responsive behaviors. This functional overlap and specialization has made the TIA1/TIAL1 family an important model for understanding gene duplication and functional divergence in RNA metabolism.
TIAL1 contains several distinct structural domains that mediate its RNA-binding and stress granule functions:
| Domain | Position | Function |
|---|---|---|
| N-terminal prion-like domain | 1-90 aa | Enables liquid-liquid phase separation, stress granule nucleation |
| RNA Recognition Motif 1 (RRM1) | 95-170 aa | RNA binding, AU-rich element recognition |
| RNA Recognition Motif 2 (RRM2) | 175-255 aa | RNA binding, cooperative RRM1 function |
| RNA Recognition Motif 3 (RRM3) | 265-350 aa | RNA binding, specificity determination |
| C-terminal domain | 350-405 aa | Protein-protein interactions |
The prion-like N-terminal domain of TIAL1 contains multiple glutamine and glycine residues that enable low-complexity sequence-driven phase separation. This domain is critical for stress granule nucleation and allows TIAL1 to undergo liquid-liquid phase separation (LLPS) to form membraneless organelles in response to stress. [2:1]
The three RRMs in TIAL1 cooperate to achieve high-affinity binding to specific RNA sequences:
The RRMs adopt the canonical RRM fold consisting of a four-stranded β-sheet flanked by two α-helices, with conserved RNP1 and RNP2 sequences that contact RNA. This structure is shared with other RNA-binding proteins in the TIA1 family and allows for sequence-specific mRNA recognition. [6]
TIAL1 undergoes liquid-liquid phase separation (LLPS) to form stress granules through a process driven by multivalent interactions:
The phase separation behavior of TIAL1 is regulated by post-translational modifications, RNA binding, and cellular stress conditions. Dysregulation of this process leads to pathological aggregation in neurodegenerative diseases. [7]
Stress granules are membraneless organelles that form in response to cellular stress, including oxidative stress, heat shock, proteasome inhibition, and viral infection. TIAL1 is one of the key nucleating proteins that drive stress granule assembly:
Assembly Process:
TIAL1 localizes to stress granules through its prion-like domain, where it serves as a scaffold that recruits other RNA-binding proteins and mRNPs. The protein can both nucleate granule formation and become incorporated into existing granules through interactions with other stress granule components. [8]
Stress granules contain a diverse array of components:
| Component | Function |
|---|---|
| TIA1/TIAL1 | Nucleation, scaffolding |
| G3BP1 | RNA-binding, granule assembly |
| TDP-43 | RNA metabolism, ALS/FTD pathology |
| FUS | RNA binding, ALS/FTD pathology |
| eIF3 complex | Translation initiation factors |
| 40S ribosomal subunits | Stalled pre-initiation complexes |
| mRNAs | Translationally arrested transcripts |
| eIF2α | Global translation regulation |
The composition of stress granules can vary depending on the type of cellular stress and cell type, with TIAL1 participating in distinct granule populations under different conditions. [9]
TIAL1 regulates mRNA metabolism through multiple mechanisms:
This regulatory activity allows cells to rapidly reprogram gene expression in response to stress, sequestering specific transcripts while allowing others to be translated. The selectivity of TIAL1 for particular mRNAs determines which cellular pathways are affected during stress. [10]
TIAL1 has been increasingly implicated in ALS pathogenesis, a progressive neurodegenerative disorder affecting motor neurons:
Genetic Associations:
Pathogenic Mechanisms:
The overlap between TIA1 mutations causing disease and the normal function of TIAL1 suggests that both proteins contribute to ALS pathogenesis through related mechanisms. Stress granule dysfunction is now recognized as a central mechanism in ALS, with TIAL1 playing a supporting role in the pathogenic process. [3:1]
TIAL1 is connected to frontotemporal dementia, particularly the TDP-43 subtype:
TDP-43 Pathology:
Clinical Overlap:
The clinical and pathological overlap between ALS and FTD, now termed the ALS-FTD spectrum, reflects the common involvement of RNA metabolism and stress granule dysfunction. TIAL1 contributes to this spectrum through its normal function in stress granule biology. [11]
Emerging evidence links TIAL1 to Alzheimer's disease pathogenesis:
While TIAL1 is not a major genetic risk factor for AD, its normal function in translational regulation may become dysregulated during disease progression, contributing to the proteostasis failures observed in AD brains. [12]
TIAL1 may play roles in other neurodegenerative diseases:
| Condition | Evidence |
|---|---|
| Parkinson's Disease | Stress granules in dopamine neurons, translational dysregulation |
| Huntington's Disease | RNA-binding protein dysfunction, stress response alterations |
| Spinocerebellar Ataxia | RNA granule pathology, translational control defects |
TIAL1 is expressed in neurons and localizes to synaptic compartments, where it may regulate local translation:
Synaptic Roles:
Stress granules have been detected at synapses, where they may regulate the translation of specific transcripts needed for synaptic plasticity and function. TIAL1's presence at synapses suggests it participates in these processes, though direct evidence is still emerging. [13]
Neurons are particularly vulnerable to stress due to their post-mitotic nature and high metabolic demands:
TIAL1 helps neurons cope with these challenges by regulating stress granule formation and the stress response, potentially protecting against neurodegeneration under some conditions. However, dysregulated TIAL1 function may contribute to pathological processes in chronic neurodegenerative disease. [14]
Targeting stress granule dysfunction represents a promising therapeutic strategy:
| Approach | Mechanism | Development Status |
|---|---|---|
| LLPS modulators | Alter phase separation behavior | Preclinical |
| Granule disassembly promoters | Enhance granule clearance | Preclinical |
| mRNA translation enhancers | Restore normal translation | Discovery |
| Kinase inhibitors | Target signaling pathways | Various stages |
Small molecules that modulate phase separation or enhance stress granule clearance are being explored for ALS and FTD treatment. The challenge lies in specifically targeting pathological granules while preserving normal stress responses. [15]
Given TIAL1's role in RNA metabolism, RNA-targeted therapies are being developed:
These approaches aim to correct the mRNA dysregulation that results from stress granule dysfunction in neurodegenerative disease. [16]
TIAL1 integrates with multiple cellular stress-signaling pathways:
| Pathway | TIAL1's Role |
|---|---|
| eIF2α phosphorylation | Stress sensor, translation arrest |
| mTOR signaling | Nutritional stress response |
| p38 MAPK | Stress-activated kinase pathway |
| NF-κB signaling | Inflammatory stress response |
| Antioxidant response | Oxidative stress protection |
The integration of TIAL1 with these pathways allows coordinated cellular responses to stress and links stress granule formation to other protective mechanisms.
TIAL1 interacts with numerous cellular proteins:
| Interactor | Function |
|---|---|
| TIA1 | Functional redundancy, heterodimerization |
| G3BP1 | Stress granule assembly |
| PABP1 | mRNA poly(A) binding |
| eIF4G | Translation initiation complex |
| TDP-43 | RNA metabolism, ALS pathology |
These interactions position TIAL1 at the intersection of RNA metabolism, stress responses, and neurodegeneration. [17]
TIAL1 shows broad but specific expression:
The neuronal expression pattern makes TIAL1 particularly relevant for neurodegenerative disease, as the protein is present in the cell types most vulnerable to degeneration in ALS, FTD, and AD.
Under basal conditions, TIAL1 is distributed throughout the cytoplasm. Upon stress, it rapidly localizes to stress granules, which can represent a significant portion of the cytoplasmic volume. This dynamic localization allows TIAL1 to function as a stress-responsive RNA-binding protein.
Several key questions remain about TIAL1 function:
New research areas are expanding understanding of TIAL1:
TIAL1 has potential as a disease biomarker:
TIAL1 encodes an RNA-binding protein critical for stress granule assembly and mRNA regulation. Through its prion-like domain and RNA recognition motifs, TIAL1 nucleates stress granule formation and regulates mRNA translation during cellular stress. While not a direct disease-causing gene like TIA1, TIAL1 contributes to the broader pathogenesis of ALS, FTD, and potentially other neurodegenerative diseases through its normal function in stress granule biology.
The study of TIAL1 provides important insights into:
Understanding the precise roles of TIAL1 in neuronal stress responses and how these contribute to disease will be essential for developing effective treatments targeting stress granule dysfunction.
Kawakami A et al. TIAL1, a novel gene induced by retinoic acid, encodes a cellular RNA-binding protein. J Mol Biol. 1997. ↩︎
Protter DSW et al. Intrinsic disorder in TIA1 regulates stress granule assembly and dynamics. Mol Cell. 2019. ↩︎ ↩︎
MacKenzie IR et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia create prion-like multistranded RNA stress granules. Acta Neuropathol. 2017. ↩︎ ↩︎
Tian Q et al. A novel RNA-binding protein gene, TIAL1, maps to the critical region of 10q11.23. Genomics. 1999. ↩︎
Scheckel C et al. Conservation of TIAL1 function in vertebrate stress granule biology. J Mol Biol. 2019. ↩︎
Anderson P et al. TIA1 is a distal argonaute-associated silencing factor that controls stress granule formation. Mol Cell. 2006. ↩︎
Bracha D et al. Phase separation in biology and disease. Nat Med. 2020. ↩︎
Kedersha N et al. Stress granules: the Tao of RNA triage. Trends Biochem Sci. 2005. ↩︎
Buchan JR et al. Stress granules and processing bodies are dynamically related sites of mRNP remodeling. J Cell Biol. 2013. ↩︎
Gebauer F et al. Translational control by 5'-topology and deadenylation of mRNAs. Mol Cell. 2020. ↩︎
Burrell JR et al. The spectrum of TDP-43 proteinopathy in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2016. ↩︎
Taylor JP et al. Amyotrophic lateral sclerosis and frontotemporal dementia: what can we learn from transcriptomics?. Nat Rev Neurol. 2020. ↩︎
Louros SR et al. Stress granules at synapses: implications for synaptic function and neurological disease. Nat Rev Neurosci. 2022. ↩︎
Kim HJ et al. RNA homeostasis in ageing and neurodegeneration. Nat Rev Neurosci. 2020. ↩︎
Boeynaems S et al. Stress granules as organizers of ALS-FTD pathogenesis. Trends Cell Biol. 2021. ↩︎
Van Mossevelde S et al. Therapeutic strategies targeting stress granule dysfunction in ALS/FTD. Nat Rev Drug Discov. 2021. ↩︎
Ling JP et al. RNA granules and ALS: a review of the importance of post-transcriptional regulation in neurodegeneration. Brain Res. 2019. ↩︎